收费全文 | 23681篇 |
免费 | 3914篇 |
国内免费 | 87篇 |
耳鼻咽喉 | 271篇 |
儿科学 | 879篇 |
妇产科学 | 740篇 |
基础医学 | 2404篇 |
口腔科学 | 649篇 |
临床医学 | 5238篇 |
内科学 | 4466篇 |
皮肤病学 | 562篇 |
神经病学 | 2308篇 |
特种医学 | 510篇 |
外国民族医学 | 1篇 |
外科学 | 3037篇 |
综合类 | 356篇 |
一般理论 | 30篇 |
预防医学 | 2843篇 |
眼科学 | 785篇 |
药学 | 1080篇 |
中国医学 | 24篇 |
肿瘤学 | 1499篇 |
2023年 | 592篇 |
2022年 | 140篇 |
2021年 | 622篇 |
2020年 | 614篇 |
2019年 | 533篇 |
2018年 | 1019篇 |
2017年 | 1021篇 |
2016年 | 991篇 |
2015年 | 1048篇 |
2014年 | 1294篇 |
2013年 | 1529篇 |
2012年 | 1286篇 |
2011年 | 1338篇 |
2010年 | 1101篇 |
2009年 | 1244篇 |
2008年 | 1085篇 |
2007年 | 1153篇 |
2006年 | 1046篇 |
2005年 | 981篇 |
2004年 | 915篇 |
2003年 | 863篇 |
2002年 | 843篇 |
2001年 | 465篇 |
2000年 | 346篇 |
1999年 | 421篇 |
1998年 | 414篇 |
1997年 | 386篇 |
1996年 | 400篇 |
1995年 | 332篇 |
1994年 | 314篇 |
1993年 | 275篇 |
1992年 | 264篇 |
1991年 | 272篇 |
1990年 | 243篇 |
1989年 | 228篇 |
1988年 | 215篇 |
1987年 | 209篇 |
1986年 | 182篇 |
1985年 | 164篇 |
1984年 | 142篇 |
1983年 | 120篇 |
1982年 | 112篇 |
1981年 | 82篇 |
1980年 | 76篇 |
1979年 | 90篇 |
1978年 | 88篇 |
1977年 | 75篇 |
1975年 | 51篇 |
1974年 | 56篇 |
1973年 | 44篇 |
Methods: The authors performed a double-blinded, placebo-controlled, multicenter trial to compare the effect of bisoprolol with that of placebo on 1-yr composite outcome including cardiovascular mortality, nonfatal myocardial infarction, unstable angina, congestive heart failure, and cerebrovascular insult. Bisoprolol was given orally before and after surgery for a maximum of 10 days. Adrenergic receptor polymorphisms and safety outcome measures of bisoprolol therapy were also determined.
Results: A total of 224 patients were enrolled. Spinal block could not be established in 5 patients. One hundred ten patients were assigned to the bisoprolol group, and 109 patients were assigned to the placebo group. The mean duration of treatment was 4.9 days in the bisoprolol group and 5.1 days in the placebo group. Bisoprolol therapy reduced mean heart rate by 10 beats/min. The primary outcome was identical between treatment groups and occurred in 25 patients (22.7%) in the bisoprolol group and 24 patients (22.0%) in the placebo group during the 1-yr follow-up (hazard ratio, 0.97; 95% confidence interval, 0.55-1.69; P = 0.90). However, carriers of at least one Gly allele of the [beta]1-adrenergic receptor polymorphism Arg389Gly showed a higher number of adverse events than Arg homozygous (32.4% vs. 18.7%; hazard ratio, 1.87; 95% confidence interval, 1.04-3.35; P = 0.04). 相似文献
Objective. To develop a highly effective and painless form of anesthesia to facilitate injection of filler substances into the lips.
Methods. Five percent lidocaine cream was applied simultaneously to the skin, vermilion, and mucosa of the lips (with the use of a barrier to keep the cream in contact with the mucosa and out of the rest of the mouth) for 20 to 30 minutes.
Results. Profound anesthesia of the lips was reliably produced, with no complications.
Conclusions. This "anesthetic cream block" is easier to perform and better tolerated than injectable anesthetics. Use of this technique is likely to expand the range of physicians who perform filler injections on the lips and will probably also expand the range of patients who wish to have filler injections done on their lips and who (because they had little or no discomfort) are willing to return for additional filler injections in the future. 相似文献